| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |